HOME > 研究紹介 > 発表論文 > 2019年

研究紹介

発表論文 - 2019年

  1. Shida W, Tateishi H, Tahara Y, Fujita M, Alsaadi DHM, Watanabe M, Koga R, Radwan MO, Ciftci HI, Gezici S, Kurauchi Y, Katsuki H, Otsuka M, Sugimura K, Wada M, Sekeroglu N, and Watanabe T.
    Antileukemic activity of twig components of Caucasian beech in Turkey.
    Molecules 24: 3850, 2019.
  2. Ciftci HI, Radwan MO, Ozturk SE, Ulusoy NG, Sozer E, Ellakwa DE, Ocak Z, Can M, Ali TFS, Abd-Alla HI, Yayli N, Tateishi H, Otsuka M, and Fujita M.
    Design, synthesis and biological evaluation of pentacyclic triterpene derivatives: Optimization of anti-ABL kinase activity.
    Molecules 24: 3535, 2019.
  3. Bayrak N, Yildirim H, Yildiz M, Radwan MO, Otsuka M, Fujita M, Tuyun AF, and Ciftici HI.
    Design, synthesis, and biological activity of plastoquinone analogs as a new class of anticancer agents.
    Bioorganic Chemistry 92: 103255, 2019.
  4. Radwan MO, Ciftci HI, Ali TFS, Ellakwa DE., Koga R, Tateishi H, Nakata A, Ito A, Yoshida M, Okamoto Y, Fujita M, and Otsuka M.
    Antiproliferative-S-trityl-L-cysteine derived compounds as SIRT2 inhibitors: Repurposing and solubility enhancement.
    Molecules 24: 3295, 2019.
  5. Ciftci HI, Bayrak N, Yildirim H, Yildiz M, Radwan MO, Otsuka M, Fujita M, and Tuyun AF.
    Discovery and structure-activity relationship of plastoquinone analogs as anticancer agents against chronic myelogenous leukemia cells.
    Archiv der Pharmazie 352: e1900170,2019.
  6. Masunaga T, Murao N, Tateishi H, Koga R, Ohsugi T, Otsuka M, and Fujita M.
    Anti-cancer activity of the cell membrane-permeable phytic acid prodrug.
    Bioorganic Chemistry 92: 103240, 2019.
  7. Nishimura N, Radwan M O, Amano M, Endo S, Fujii E, Hayashi H, Ueno S, Ueno N, Tatetsu H, Hata H, Okamoto Y, Otsuka M, Mitsuya H, Matsuoka M, and Okuno Y.
    Novel p97/VCP inhibitor induces endoplasmic reticulum stress and apoptosis in both bortezomib‐sensitive and ‐resistant multiple myeloma cells.
    Cancer Science 110: 3275-3287, 2019.
  8. Sever B, Altintop MD, Radwan MO, Ozdemir A, Otsuka M, Fujita M, and Ciftci H I.
    Design, synthesis and biological evaluation of a new series of thiazolyl-pyrazolines as dual EGFR and HER2 inhibitors.
    European Journal of Medicinal Chemistry 182: 111648, 2019.
  9. Radwan MO, Koga R, Hida T, Ejima T, Kanemaru Y, Tateishi H, Okamoto Y, Inoue J, Fujita M, and Otsuka M.
    Minimum structural requirements for inhibitors of the zinc finger protein TRAF6.
    Bioorganic & Medicinal Chemistry Letters 29: 2162-2167, 2019.
  10. Ali TFS, Ciftci HI, Radwan MO, Koga R, Ohsugi T, Okiyama Y, Honma T, Nakata A, Ito A, Yoshida M, Fujita M, and Otsuka M.
    New SIRT2 inhibitors: Histidine-based bleomycin spin-off.
    Bioorganic & Medicinal Chemistry 27: 1767-1775, 2019.
  11. Ciftci HI, Sierra RG, Yoon CH, Su Z, Tateishi H, Koga R, Koiwai K, Yumoto F, Senda T, Liang M, Wakatsuki S, Otsuka M, Fujita M, and DeMirci H.
    Serial femtosecond X-ray diffraction of HIV-1 Gag MA-IP6 microcrystals at ambient temperature.
    International Journal of Molecular Sciences 20: 1675, 2019.
  12. Noguchi K, Ali TFS, Miyoshi J, Orito K, Negoto T, Biswas T, Taira N, Koga R, Okamoto Y, Fujita M, Otsuka M, and Morioka M.
    Neuroprotective effects of a novel carnosine-hydrazide derivative on hippocampal CA1 damage after transient cerebral ischemia.
    European Journal of Medicinal Chemistry 163: 207-214, 2019.
  13. El-Shaheny R, Radwan M, Yamada K, and El-Maghrabey, M.
    Estimation of nizatidine gastric nitrosatability and product toxicity via an integrated approach combining HILIC, in silico toxicology, and molecular docking.
    Journal of Food and Drug Analysis 27: 915-925, 2019.
  14. El-Shaheny R, Fuchigami T, Yoshida S, Radwan MO, and Nakayama M.
    Complementary HPLC, in silico toxicity, and molecular docking studies for investigation of the potential influences of gastric acidity and nitrite content on paracetamol safety.
    Microchemical Journal 150, 104107, 2019.